NS · Pharmaceuticals

Unichem Laboratories Ltd (UNICHEMLAB)

Pharmaceuticals & Biotechnology

Unichem Laboratories Ltd (UNICHEMLAB) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-11, reported market cap is $30.73B, P/E ratio is 19.34, net margin is 4.6%, dividend yield is 0.92%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for UNICHEMLAB

Market cap

$30.73B

P/E ratio

19.34

Net margin

4.6%

Dividend yield

0.92%

Unichem Laboratories Ltd (UNICHEMLAB) — FAQ

What is Unichem Laboratories Ltd's market cap?

Unichem Laboratories Ltd (UNICHEMLAB) has a reported market cap of $30.73B (data as of 2026-07-11).

What is UNICHEMLAB's P/E ratio?

The price-to-earnings (P/E) ratio for Unichem Laboratories Ltd (UNICHEMLAB) is 19.34 (data as of 2026-07-11).

Does Unichem Laboratories Ltd pay a dividend?

Unichem Laboratories Ltd (UNICHEMLAB) shows a reported dividend yield of 0.92%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-11).

What sector is Unichem Laboratories Ltd in?

Unichem Laboratories Ltd (UNICHEMLAB) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is UNICHEMLAB listed on?

UNICHEMLAB is listed on NS.

What is Unichem Laboratories Ltd's net margin?

Unichem Laboratories Ltd (UNICHEMLAB) reports a net margin of 4.6% (data as of 2026-07-11).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)